about us

products technology press careers
in the news

Wave 80 Biosciences is an early-stage biotechnology company focused on developing, manufacturing, marketing, and selling innovative molecular diagnostics instruments and consumables for infectious disease, cancer, and other human health conditions.  Wave 80's pipeline molecular diagnostics products address major unmet needs of patient populations in the U.S., Europe, and Japan, as well as in emerging economies such as China and Brazil

Wave 80, Siemens team up on HIV viral load measurement

With NIH support, initiative seeks to develop innovative tools for guiding antiretroviral therapy

San Francisco, California and Tarrytown, New York, October 19, 2007 – Targeting a major area of need in the global fight against HIV/AIDS, Wave 80 and Siemens Medical Solutions Diagnostics today announced the beginning of a new research initiative focused on technologies to complement pharmaceutical strategies for helping patients diagnosed with HIV lead longer, more productive lives. 

More

Wave 80 to make EOSCAPE assay cartridge technology kernel available for out-license

Innovative, low-cost technology offers high-temporal-resolution control over transport of samples and reagents within disposable assay cartridges

San Francisco, CA, July 9, 2007 – Wave 80 announced today that a key component of EOSCAPE, its powerful technology for modular analytical systems, will be available for license by select partners in the clinical laboratory systems industry beginning in Q4 2007.

More

Wave 80 malaria diagnostic selected for oral presentation at prestigious Oak Ridge conference

Emerging technologies forum will showcase research on ultraminature device for measuring disease markers in fingerstick blood samples

San Francisco, California, March 7, 2007 – Dr. Daniel Laser, Wave 80’s CEO and President, will give an invited talk at the 39th Annual Oak Ridge conference:  Harnessing New Technology for Clinical Diagnostics.  The annual Oak Ridge meeting is sponsored by American Association for Clinical Chemistry and brings together thought leaders in diagnostics methods and instrumentation.  The 2007 meeting will be held in St. Louis, Missouri on April 18-19, 2007. 

More

copyright 2008 wave 80 biosciences, inc.  san francisco, california
innovation in molecular diagnostics